Funding & M&A
Ardan Equity Completes Investment in Clinical Ink, First Deal From Fund I
Ardan Equity has completed its investment in Clinical ink, a clinical trial technology company, according to a statement from the investor. The deal is the first investment made from Ardan Equity Fund I.
By The Desk - Jordan Leahy·October 28, 2026
The announcement did not disclose the size of the investment or the stake acquired. Ardan said it will partner with GI and Clinical ink going forward.
Clinical ink is described in the statement as a clinical trial technology company. Further terms of the transaction were not provided in the source material.